GSTO1 and COVID-19: Namely, the odds of COVID-19 development were significantly increased among individuals with variant GSTO1*AA genotype compared to the GSTO1*CC homozygotes (OR = 2.45 95%CI: 1.03–5.84, p = 0.044).